Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 26,300
-1,350 (-4.88%)
At close: Nov 13, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 217.69 billion as of November 13, 2026. It is the 21,586th most valuable company in the world and the 740th biggest in South Korea. Its market cap has decreased by 57.41% in one year.
Market Cap
217.69B
Enterprise Value
189.65B
Revenue
17.79B
Global Rank
Country Rank
#740 South Korea
PE Ratio
925.72
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 217.69B, an increase of 14.70%. That is a compound annual growth rate of 6.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 217.69B | -70.32% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 183.81B |
| Mezoo | 167.50B |
| MEDIANA Co.,Ltd | 141.15B |
| L&K Biomed | 112.65B |
| Remed | 73.16B |
| Hironic | 66.30B |
| SELVAS Healthcare | 64.04B |
| DRGEM | 53.61B |